The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII.EBI
University of Pisa
QSAR studies on BK channel activators.EBI
University of Pisa
Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers.EBI
University of Pisa
New amido derivatives as potential BKCa potassium channel activators. XI.EBI
University of Pisa
Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.EBI
University of North Texas Health Science Center
Discovery, synthesis and biological characterization of a series of EBI
University of Nebraska
The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure-activity relationships of 2-amino-4-azaindoles.EBI
Abbott Laboratories